This company has been marked as potentially delisted and may not be actively trading. Gelesis (GLS) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock GLS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Gelesis Holdings Inc GLSHQDecember 9, 2023 | morningstar.comMNYSE to suspend trading immediately in Gelesis HoldingsApril 11, 2023 | msn.comNYSE to Suspend Trading Immediately in Gelesis Holdings, Inc. (GLS) and Commence Delisting ProceedingsApril 10, 2023 | finance.yahoo.comGelesis (NYSE:GLS) HeadlineTrading was temporarily halted for "GLS" at 04:04 PM with a stated reason of "News pending."...April 10, 2023 | marketbeat.comLooking Into Gelesis Holdings's Return On Capital EmployedMarch 29, 2023 | msn.comGelesis Reports Fourth Quarter and Full Year 2022 ResultsMarch 28, 2023 | finance.yahoo.comGLS Gelesis Holdings, Inc.January 27, 2023 | seekingalpha.comGelesis to Participate in the 25th Annual ICR ConferenceJanuary 5, 2023 | finance.yahoo.comNYSE to Suspend Trading Immediately in Warrants of Gelesis Holdings, Inc. (GLS WS) and Commence Delisting ProceedingsJanuary 4, 2023 | technews.tmcnet.comGelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth ConferenceNovember 21, 2022 | finance.yahoo.comGelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-ComplianceNovember 18, 2022 | finance.yahoo.comGelesis Holdings, Inc. (GLS) Q3 2022 Earnings Call TranscriptNovember 14, 2022 | seekingalpha.comGelesis Reports Third Quarter 2022 ResultsNovember 14, 2022 | finance.yahoo.comGelesis to Report Third Quarter 2022 Financial Results on November 14, 2022November 7, 2022 | finance.yahoo.comGelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-ComplianceNovember 4, 2022 | finance.yahoo.comData Presented at Obesity Week Demonstrate that Gelesis Investigational Clinical-Stage Oral Superabsorbent Hydrogel Gel-B Preferentially Enhances the Growth of Akkermansia muciniphila in Preclinical Models Compared to PrebioticsNovember 2, 2022 | finance.yahoo.comDr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis’ Oral Hydrogel Treatment GS200 at Obesity WeekNovember 1, 2022 | finance.yahoo.comInvestors in Gelesis Holdings (NYSE:GLS) have unfortunately lost 89% over the last yearOctober 5, 2022 | ca.finance.yahoo.comGelesis Holdings Inc GLS Stock AnalysisSeptember 9, 2022 | morningstar.comMGelesis to Participate in the Jefferies Virtual Fitness & Wellness SummitSeptember 8, 2022 | finance.yahoo.comClinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic SyndromeAugust 25, 2022 | finance.yahoo.comInvestors one-year losses grow to 89% as the stock sheds US$21m this past weekAugust 24, 2022 | nasdaq.comREPLAY: Fight Obesity With Biotech – Gelesis CEO, CFO in Fireside ChatAugust 17, 2022 | finance.yahoo.comAnalyzing Gelesis Holdings Short InterestAugust 17, 2022 | msn.comGelesis to Participate in Fireside Chat with IPO Edge Today at 2:00 PM ETAugust 17, 2022 | finance.yahoo.comArming Consumers to Fight Obesity with Biotech – Join CEO and CFO of Gelesis in Fireside Chat Wednesday at 2 ETAugust 16, 2022 | finance.yahoo.comGelesis Holdings, Inc. (GLS) CEO Yishai Zohar on Q2 2022 Results - Earnings Call TranscriptAugust 15, 2022 | seekingalpha.comGelesis Reports Second Quarter 2022 ResultsAugust 15, 2022 | finance.yahoo.comGelesis to Report Second Quarter 2022 Financial Results on August 15, 2022August 4, 2022 | finance.yahoo.comGelesis announces additional $15M pre-order for PlenityJune 21, 2022 | seekingalpha.comRaju S. Kucherlapati Buys 24,625 Shares of Gelesis Holdings, Inc. (NYSE:GLS) StockJune 17, 2022 | marketbeat.comOver the Past Decade, Person-First Language Was Used in Only About Half of Diabetes-Focused Articles and Fewer than 1% of Obesity Articles, Finds New StudyJune 5, 2022 | finance.yahoo.comMicrobiota Transplantation Demonstrates How Gut Bacteria Contributes to Weight Loss and Beneficial Metabolic Effects with Gelesis’ Proprietary HydrogelJune 4, 2022 | finance.yahoo.comGelesis Holdings, Inc. Common Stock (GLS)May 28, 2022 | nasdaq.comGelesis Holdings Inc (GLS)May 27, 2022 | investing.comGelesis to Participate in Upcoming Investor ConferencesMay 18, 2022 | finance.yahoo.comGelesis Holdings' (GLS) CEO Yishai Zohar on Q1 2022 Results - Earnings Call TranscriptMay 14, 2022 | seekingalpha.comGelesis Holdings GAAP EPS of -$0.70, revenue of $7.51MMay 13, 2022 | seekingalpha.comGelesis to Report First Quarter 2022 Financial Results on May 12, 2022May 9, 2022 | finance.yahoo.comClinical Data Presented at the European Congress on Obesity 2022 Demonstrates Weight Loss With GS200 in Adults With Prediabetes and Type 2 DiabetesMay 4, 2022 | finance.yahoo.comGelesis’ Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New StudyApril 29, 2022 | finance.yahoo.comGelesis (NYSE:GLS) HeadlineTrading was temporarily halted for "GLS" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM. February 18, 2022 | marketbeat.com Get Gelesis News Delivered to You Automatically Sign up to receive the latest news and ratings for GLS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GLS Media Mentions By Week GLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLS News Sentiment▼0.000.75▲Average Medical News Sentiment GLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLS Articles This Week▼00▲GLS Articles Average Week Get the Latest News and Ratings for GLS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Gelesis and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Eagle Pharmaceuticals News PyroGenesis Canada News NanoViricides News iBio News AEON Biopharma News China Pharma News Orgenesis News Avenue Therapeutics News Can-Fite BioPharma News Evofem Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GLS) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredWhat the hell is going on, America?America’s $37.5 trillion debt spiral, soaring deficits, and repeated credit downgrades are exactly what Porter...Porter & Company | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gelesis Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gelesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
